• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对可溶性人肿瘤坏死因子受体(肿瘤坏死因子结合蛋白)的单克隆抗体增强了其阻断肿瘤坏死因子毒性的能力。

Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity.

作者信息

Adolf G R, Frühbeis B

机构信息

Department of Cell Biology, Ernst Boehringer-Institut für Arzneimittelforschung, Bender + Co Ges mbH, Vienna, Austria.

出版信息

Cytokine. 1992 May;4(3):180-4. doi: 10.1016/1043-4666(92)90053-t.

DOI:10.1016/1043-4666(92)90053-t
PMID:1379835
Abstract

A soluble extracellular fragment of the human 55-60 kDa tumor necrosis factor receptor (sTNF-R I), originally isolated from urine, binds both TNF-alpha and TNF-beta and blocks the activity of these cytokines in biological assays. Three monoclonal antibodies (mAbs) raised against sTNF-R I (TBP-1, -2 and -6) as well as a mAb developed by immunization with the intact receptor (H398) were analysed for their epitope specificities in ELISAs and for biological activity in cytotoxicity assays on murine L-M cells. TBP-2 and H398 bind to related epitopes on sTNF-R I; they compete with TNF-alpha for binding and block the protective effect of sTNF-R I in the bioassay. MAbs TBP-1 and TBP-6 recognize two further, independent epitopes; both bind sTNF-R I in the presence of an excess of TNF-alpha. Both TBP-1 and TBP-6 markedly enhance the ability of sTNF-R I to protect cells against the cytotoxic activities of TNF-alpha and TNF-beta, but have no activity in the absence of sTNF-R I. Fab fragments show much lower activity. We propose that the ability of certain mAbs to enhance the protective activity of sTNF-R is due to a steric hindrance phenomenon.

摘要

人55 - 60 kDa肿瘤坏死因子受体(sTNF - R I)的可溶性细胞外片段最初从尿液中分离得到,它能结合TNF -α和TNF -β,并在生物学检测中阻断这些细胞因子的活性。分析了三种针对sTNF - R I产生的单克隆抗体(mAb,TBP - 1、- 2和 - 6)以及一种用完整受体免疫制备的单克隆抗体(H398)在酶联免疫吸附测定(ELISA)中的表位特异性,以及在小鼠L - M细胞的细胞毒性检测中的生物学活性。TBP - 2和H398结合sTNF - R I上的相关表位;它们与TNF -α竞争结合,并在生物检测中阻断sTNF - R I的保护作用。单克隆抗体TBP - 1和TBP - 6识别另外两个独立的表位;在TNF -α过量存在时,它们都能结合sTNF - R I。TBP - 1和TBP - 6都显著增强sTNF - R I保护细胞免受TNF -α和TNF -β细胞毒性作用的能力,但在没有sTNF - R I时没有活性。Fab片段的活性要低得多。我们认为某些单克隆抗体增强sTNF - R保护活性的能力是由于空间位阻现象。

相似文献

1
Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity.针对可溶性人肿瘤坏死因子受体(肿瘤坏死因子结合蛋白)的单克隆抗体增强了其阻断肿瘤坏死因子毒性的能力。
Cytokine. 1992 May;4(3):180-4. doi: 10.1016/1043-4666(92)90053-t.
2
Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody.肿瘤坏死因子(TNF)-1型受体(p55)的一个表位的鉴定,该表位可被一种TNF-α拮抗剂单克隆抗体识别。
Lymphokine Cytokine Res. 1994 Jun;13(3):183-90.
3
Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.1型肿瘤坏死因子受体重组细胞外结构域的特性:肿瘤坏死因子-α诱导受体聚集的证据
Biochemistry. 1992 Feb 4;31(4):1134-41. doi: 10.1021/bi00119a023.
4
A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids.一种基于单克隆抗体的酶免疫测定法,用于定量检测生物体液中的人肿瘤坏死因子结合蛋白I(60 kDa肿瘤坏死因子受体的可溶性片段)。
J Immunol Methods. 1991 Sep 20;143(1):127-36. doi: 10.1016/0022-1759(91)90281-j.
5
In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.可溶性肿瘤坏死因子受体p75(TBP II)与可溶性肿瘤坏死因子受体p55(TBP I)对肿瘤坏死因子-α和肿瘤坏死因子-β抑制能力的体外比较。
J Interferon Cytokine Res. 1996 Dec;16(12):1047-53. doi: 10.1089/jir.1996.16.1047.
6
Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations.通过酶联免疫吸附测定法(ELISA)和生物测定法对肿瘤坏死因子(TNF)α进行定量:分析孵育过程中TNFα-可溶性TNF受体(p55)复合物解离的影响。
J Immunol Methods. 1994 Dec 28;177(1-2):191-8. doi: 10.1016/0022-1759(94)90156-2.
7
Epitope mapping and functional analysis of three murine IgG1 monoclonal antibodies to human tumor necrosis factor-alpha.三种抗人肿瘤坏死因子-α的小鼠IgG1单克隆抗体的表位作图及功能分析
J Immunol. 1993 Sep 1;151(5):2707-16.
8
Protective effect of natural TNF-binding protein on human TNF-induced toxicity in mice.
Cytokine. 1993 Sep;5(5):459-62. doi: 10.1016/1043-4666(93)90036-5.
9
Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.75千道尔顿肿瘤坏死因子受体胞外域的生化特性
Biochemistry. 1993 Mar 30;32(12):3131-8. doi: 10.1021/bi00063a027.
10
The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.类风湿性关节炎患者血清中肿瘤坏死因子受体/配体家族
Eur Cytokine Netw. 1998 Jun;9(2):145-54.

引用本文的文献

1
Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.肿瘤坏死因子-α(TNF-α)及其受体在正常皮肤和银屑病皮肤中的定位:表皮细胞表达55-kD的TNF受体,但不表达75-kD的TNF受体。
Clin Exp Immunol. 1993 Nov;94(2):354-62. doi: 10.1111/j.1365-2249.1993.tb03457.x.
2
Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions.
Clin Exp Immunol. 1994 Apr;96(1):146-51. doi: 10.1111/j.1365-2249.1994.tb06244.x.
3
The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum.
Surg Today. 1994;24(3):197-202. doi: 10.1007/BF02032887.
4
Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia.在狒狒菌血症模型中肿瘤坏死因子(TNF)依赖性的p55 TNF受体脱落
Infect Immun. 1995 Jan;63(1):297-300. doi: 10.1128/iai.63.1.297-300.1995.
5
Pattern of soluble TNF receptors I and II in sepsis.脓毒症中可溶性肿瘤坏死因子受体I和II的模式
Infection. 1995 May-Jun;23(3):143-8. doi: 10.1007/BF01793854.